Lifeloc Technologies, Inc. announced the results of a study aimed at determining risk of subject to subject virus transmission through their FC Series (Phoenix 6.0, EV30, FC20, etc.) and L Series (LX9, LT7, LT7I) breath alcohol testing products. The study, which was commissioned by Lifeloc, simulated a breath alcohol test performed on a highly infected test subject by pumping approximately 2 million MS2 Bacteriophage virus particles through a mouthpiece to simulate an infected subject. The MS2 virus was used in the study as a surrogate for common infectious viruses. After the highly infected test subject simulation, a following breath alcohol test was performed to evaluate risk of cross-contamination on test subjects. Analysis of the air pulled through multiple mouthpieces found no detectable viruses with the FC Series and L Series units. This analysis was done by an independent test laboratory familiar with testing bioactive hazard risks. Only Lifeloc-brand breath alcohol testers were examined and were demonstrated to not present this risk.